DKK3 and prostate cancer: In both the mouse renal cell carcinoma (RENCA cells) (Fig. 4A) and human prostate cancer (PC3 cells) (Fig. 4B) models, strong suppression of tumor growth was observed in the Ad-SGE-REIC-treated groups in comparison to the other treatment groups.